Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy (2021)
- Authors:
- Vigón, Lorena
- Román, Paula Martínez
- Mora, Sara Rodríguez
- Torres, Montserrat
- Puertas, María C
- Mateos, Elena
- Salgado, María
- Navarro, Antonio
- Conde, Matilde Sánchez
- Ambrosioni, Juan
- Cervero, Miguel
- Wyen, Christoph
- Hoffmann, Christoph M.
- Miró, José M
- Alcamí, José
- Podzamczer, Daniel
- Gutiérrez, Valentín García
- Picado, Javier Martínez
- Briz, Verónica
- Huertas, María Rosa López
- Planelles, Vicente
- Coiras, Mayte
- Autor USP: HOFFMANN, CHRISTIAN - FCF
- Unidade: FCF
- DOI: 10.1016/j.bcp.2021.114666
- Subjects: HIV; ANTIRRETROVIRAIS; ADJUVANTES IMUNOLÓGICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2021
- Source:
- Título: Biochemical Pharmacology
- ISSN: 0006-2952
- Volume/Número/Paginação/Ano: v. 192, p. 1-34 art. 114666, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
VIGÓN, Lorena et al. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy. Biochemical Pharmacology, v. 192, p. 1-34 art. 114666, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114666. Acesso em: 27 dez. 2025. -
APA
Vigón, L., Román, P. M., Mora, S. R., Torres, M., Puertas, M. C., Mateos, E., et al. (2021). Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy. Biochemical Pharmacology, 192, 1-34 art. 114666. doi:10.1016/j.bcp.2021.114666 -
NLM
Vigón L, Román PM, Mora SR, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Conde MS, Ambrosioni J, Cervero M, Wyen C, Hoffmann CM, Miró JM, Alcamí J, Podzamczer D, Gutiérrez VG, Picado JM, Briz V, Huertas MRL, Planelles V, Coiras M. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy [Internet]. Biochemical Pharmacology. 2021 ; 192 1-34 art. 114666.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.bcp.2021.114666 -
Vancouver
Vigón L, Román PM, Mora SR, Torres M, Puertas MC, Mateos E, Salgado M, Navarro A, Conde MS, Ambrosioni J, Cervero M, Wyen C, Hoffmann CM, Miró JM, Alcamí J, Podzamczer D, Gutiérrez VG, Picado JM, Briz V, Huertas MRL, Planelles V, Coiras M. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy [Internet]. Biochemical Pharmacology. 2021 ; 192 1-34 art. 114666.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.bcp.2021.114666 - Comparison of gut microbiota composition between peritoneal dialysis patients and healthy household contacts
- The microbiota vault initiative: safeguarding Earth’s microbial heritage for future generations
- Lung Epithelial CYP1 activity regulates aryl hydrocarbon receptor dependent allergic airway inflammation
- The human gut microbiota: Metabolism and perspective in obesity
- A pilot characterization of the human chronobiome
- Kicking sleepers out of bed: macrophages promote reactivation of dormant Cryptococcus neoformans by extracellular vesicle release and non-lytic exocytosis
- Therapeutic potential of the intestinal microbiota for immunomodulation of food allergies
- Enterótipos: interesse e aplicações
- Probiotics for obesity and metabolic syndrome prevention and treatment
- População Ribeirinha do Rio Solimões na Amazônia brasileira apresenta uma microbiota oral da placa supragengival característica e correlacionada com a dieta
Informações sobre o DOI: 10.1016/j.bcp.2021.114666 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3052875.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
